Skip to main content
Konstantine Halkidis, MD, Oncology, Birmingham, AL

Konstantine Halkidis MD


Physician

Join to View Full Profile
  • 1802 6th Ave SBirmingham, AL 35233

  • Phone+1 205-934-3411

Dr. Halkidis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2014 - 2017
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2014

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2021 - 2026
  • KS State Medical License
    KS State Medical License 2020 - 2025
  • AL State Medical License
    AL State Medical License 2017 - 2020
  • PA State Medical License
    PA State Medical License 2014 - 2017
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Exome Sequencing Identifies Glycosylation Defects As a Probable Cause of Immune Thrombotic Thrombocytopenic Purpura
    Konstantine Halkidis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Plasma Levels of Histone-DNA Complex and Cell-Free DNA Predict Mortality in Patients with Immune Thrombotic Thrombocytopenic Purpura
    Konstantine Halkidis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Longitudinal Assessment of Plasma ADAMTS13 Biomarkers Helps Predict Recurrence of Immune Thrombotic Thrombocytopenic Purpura
    Konstantine Halkidis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Grant Support

  • Exploring the mechanisms of action of anti-ADAMTS 13 antibodies in immune thrombotic thrombocytopenic purpuraUNIVERSITY OF KANSAS MEDICAL CENTER2022–2027

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: